KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Celltrion

Celltrion at Second Stage of Vaccine Development Against COVID-19

KoreaTechToday Editor by KoreaTechToday Editor
PUBLISHED: April 2, 2020 UPDATED: April 5, 2020
in Celltrion, Korea Centers for Disease Control and Prevention, South Korea, Vaccine, Virus
0
celltrion
Celltrion started to select through screening the most effective antibodies to neutralize COVID-19.

Celltrion started to select through screening the most effective antibodies to neutralize COVID-19.

Celltrion said on Thursday that the company started to select through screening the most effective antibodies to neutralize the virus. The screening came after the biologics firm completed its first stage development for an antiviral treatment for the COVID-19.

The Korean company said that it is determined to continue the project despite the uncertainty about the COVID-19 vaccine development.

Suh Jung-jin, Celltrion’s chairman, assured that on April 23, he would share with the public any progress or news that the company makes to help prevent the rapid spread of the new coronavirus.

Alongside the Korea Centers for Disease Control and Prevention (KCDC), Celltrion began screening for a second candidate antibody group. The company aims to complete the screening within two weeks.

After proving that the most potent antibody candidate could counteract the virus, the company would begin the mass production of the therapeutics for clinical trials. The firm would also simultaneously conduct non-clinical studies on lab animals.

Researchers noted a promising outcome as the previously identified antibodies demonstrated a higher binding affinity to an antigen than what the company used in past antiviral treatment projects.

Celltrion said that it commits itself to create a therapeutic antibody available for human usage as soon as possible. The company added that it would utilize all available human resources to accelerate the project’s development further.

A Celltrion spokesperson said that with the company’s state-of-of-the-art research and development capabilities of antibody drugs, Celltrion would conduct human clinical administration as early as July. The spokesperson added that they would proceed with the clinical trials in a shorter time than any other pharmaceutical company internationally.

Celltrion said that it would expedite the clinical trials to faster help the global community in battling the coronavirus pandemic.

WHO Update

According to the World Health Organization (WHO), the total number of confirmed cases in the world reached 1,039,166 cases, with 55,092 deaths and 219,019 recovered patients. The United States has the highest confirmed cases of 245,974.

Tags: antibodybiologicsCelltrioncoronavirusCOVID-19KCDCkorea newsSouth Koreavaccine

Related Posts

South Korea, BlackRock Team Up to Build Hyperscale AI Data Center Hub
Celltrion started to select through screening the most effective antibodies to neutralize COVID-19.
Data Center

South Korea, BlackRock Team Up to Build Hyperscale AI Data Center Hub

October 1, 2025
Global API Standardization Gets a Push with SK Telecom–Aduna Partnership
Celltrion started to select through screening the most effective antibodies to neutralize COVID-19.
AI

Global API Standardization Gets a Push with SK Telecom–Aduna Partnership

September 23, 2025
$12B Crypto Wave: How Young Koreans Are Shaping Global Markets
Celltrion started to select through screening the most effective antibodies to neutralize COVID-19.
Cryptocurrency

$12B Crypto Wave: How Young Koreans Are Shaping Global Markets

September 1, 2025
Caught Between Giants: How U.S. Export Controls Reshape South Korea’s Semiconductor Strategy
Celltrion started to select through screening the most effective antibodies to neutralize COVID-19.
Samsung

Caught Between Giants: How U.S. Export Controls Reshape South Korea’s Semiconductor Strategy

September 1, 2025
Samsung and SK Hynix Face New U.S. Licensing Rules for Chinese Chip Plants
Celltrion started to select through screening the most effective antibodies to neutralize COVID-19.
China

Samsung and SK Hynix Face New U.S. Licensing Rules for Chinese Chip Plants

August 31, 2025
South Korea Eyes Global AI Leadership with Record 8.1% Budget Hike
Celltrion started to select through screening the most effective antibodies to neutralize COVID-19.
AI

South Korea Eyes Global AI Leadership with Record 8.1% Budget Hike

August 30, 2025
No Result
View All Result

Most Popular

  • Ride-Hailing Rivalry: Kakao and Uber Bet on Membership Services in Korea

    0 shares
    Share 0 Tweet 0
  • Kakao Mobility Faces $10.5 Million Fine for Limiting Competitors’ Access to Taxi Platform

    0 shares
    Share 0 Tweet 0
  • Korea’s Navigation Battle Heats Up: Naver and Kakao vs. Google maps

    0 shares
    Share 0 Tweet 0
  • 5 Best Korean to English Translation Apps

    0 shares
    Share 0 Tweet 0
  • Naver Launches 3D Street View for Immersive Navigation Experience

    0 shares
    Share 0 Tweet 0
  • KakaoTalk to Adopt Instagram-Style Feed in Major 2025 Redesign

    0 shares
    Share 0 Tweet 0
  • Naver Maps Launches Guide in English, Chinese, and Japanese to Enhance Travel Experience for Tourists

    0 shares
    Share 0 Tweet 0
  • Top Nine Mobile MMORPG in South Korea for 2020

    0 shares
    Share 0 Tweet 0
  • Naver Unveils Asia’s Largest Data Center, GAK Sejong, for Tech Innovation

    0 shares
    Share 0 Tweet 0
  • South Korea Invests $1.1B to Build National AI GPU Infrastructure

    0 shares
    Share 0 Tweet 0

PRODUCTS

[ads_amazon]

TOPICS

  • Naver
  • Kakao
  • Nexon
  • Netmarble
  • NCsoft
  • Samsung
  • Hyundai

FREE NEWSLETTER

FOLLOW US

  • About Us
  • Cookie policy
  • home
  • homepage
  • mainhome
  • Our Services
  • Privacy Policy
  • Terms of Use

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |

No Result
View All Result
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |